Back to Journals » ClinicoEconomics and Outcomes Research » Volume 4

Maintenance erlotinib in advanced nonsmall cell lung cancer: cost-effectiveness in EGFR wild-type across Europe

Total article views   HTML views PDF downloads Totals
14,110 Dovepress* 12,749+ 2,260 15,009
PubMed Central* 1,361 660 2,021
Totals 14,110 2,920 17,030
*Since 14 September 2012
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 0 4

View citations on PubMed Central and Google Scholar